BLAINTRAMUSCULARSUSPENSION
Approved
May 2024
Lifecycle
Growth
Competitive Pressure
30/100
Clinical Trials
9
Clinical Trials (5)
Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell)
Started Oct 2025
A Study on the Immunogenicity and Safety of 3 Different Dose Concentrations of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers
Started Nov 2024
947 enrolled
RSV Immunisation
Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers
Started May 2024
2,226 enrolled
RSV Immunization
Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers
Started Feb 2024
6,300 enrolled
RSV Immunisation
Study on a Live-attenuated Respiratory Syncytial Virus Vaccine for Assessment of Safety, Transmissibility, and Genetic Stability of the Vaccine Virus Among Close Contacts in Infants and Toddlers 6 to < 24 Months of Age in Puerto Rico (USA)
Started Feb 2023
80 enrolled
Respiratory Syncytial Virus Infection